Eunice Ikongo
YOU?
Author Swipe
View article: Inclisiran patient experiences survey
Inclisiran patient experiences survey Open
Introduction Inclisiran is a small interfering ribonucleic acid (siRNA), which increases LDL-C receptor recycling with a projected reduction of 50% in LDL-C. It is a twice a year injectable, licensed in the UK in January 2021. There has be…
View article: Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors
Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors Open
Background Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9is) are an important but underutilised option to help optimise lipid management. We developed a new service to improve patient access to these medicines in line with…